Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.30 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL9188708 | 0.99 | TDP1 (0.38) | TDP1POLBAPEX1HTTTHRB | |
| SCHEMBL29120840 | 0.82 | TDP1 (0.41) | TDP1POLBAPEX1HTTTHRB | |
| SCHEMBL9312827 | 0.82 | TDP1 (0.49) | TDP1POLBAPEX1HTTTHRB | |
| SCHEMBL4566748 | 0.81 | TDP1 (0.54) | TDP1POLBAPEX1HTTTHRB | |
| SCHEMBL6985652 | 0.77 | TDP1 (0.55) | TDP1POLBAPEX1HTTTHRB | |
| Methacrylic Acid SCHEMBL9469984 | 0.76 | TDP1 (0.35) | TDP1POLBAPEX1HTTTHRB | |
| SCHEMBL2116688 | 0.76 | TDP1 (0.40) | TDP1POLBAPEX1HTTTHRB | |
| Styrene SCHEMBL9010621 | 0.75 | TDP1 (0.39) | TDP1POLBAPEX1HTTTHRB | |
| SCHEMBL28116495 | 0.75 | THRB (0.43) | TDP1POLBAPEX1HTTTHRB | |
| Water SCHEMBL19406075 | 0.72 | TDP1 (0.43) | TDP1POLBAPEX1HTTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8858961-B2 | Compositions containing alpha-2-adrenergic agonist components | ALLERGAN, INC. (US) | 2014-10-14 | — | — | US | disclosed |
| US-20090312337-A1 | COMPOSITIONS CONTAINING ALPHA-2-ADRENERGIC AGONIST COMPONENTS | ALLERGAN, INC. (US) | 2009-12-17 | — | — | US | disclosed |
| EP-1654002-A2 | COMPOSITIONS FOR DELIVERY OF THERAPEUTICS INTO THE EYES AND METHODS FOR MAKING AND USING THE SAME | Allergan, Inc. (US) | 2006-05-10 | — | — | EP | disclosed |
| EP-1605912-A2 | PRESERVED OPHTHALMIC COMPOSITIONS | Allergan, Inc. (US) | 2005-12-21 | — | — | EP | disclosed |
| WO-2005032577-A1 | USE OF CYCLOSPORIN COMPONENTS IN OPHTALMIC CONDITIONS | ALLERGAN, INC. (US) | 2005-04-14 | — | — | WO | disclosed |
| WO-2005014046-A2 | COMPOSITIONS FOR DELIVERY OF THERAPEUTICS INTO THE EYES AND METHODS FOR MAKING AND USING THE SAME | ALLERGAN, INC. (US) | 2005-02-17 | — | — | WO | disclosed |
| WO-2004087098-A2 | PRESERVED OPHTHALMIC COMPOSITIONS | ALLERGAN, INC. (US) | 2004-10-14 | — | — | WO | disclosed |
| EP-1390073-A2 | COMPOSITIONS HAVING ENHANCED PHARMACOKINETIC CHARACTERISTICS | Allergan, Inc. (US) | 2004-02-25 | — | — | EP | disclosed |
| WO-2003051332-A1 | OPHTHALMIC COMPOSITIONS COMPRISING TWO DIFFERENT POLYANIONIC COMPONENTS FOR LUBRICATING EYES AND METHODS FOR MAKING AND USING SAME | ALLERGAN, INC. (US) | 2003-06-26 | — | — | WO | disclosed |
| WO-2002089853-A2 | COMPOSITIONS HAVING ENHANCED PHARMACOKINETIC CHARACTERISTICS | ALLERGAN, INC. (US) | 2002-11-14 | — | — | WO | disclosed |
| EP-0835142-A1 | COMPOSITIONS AND METHODS FOR DISINFECTING A CONTACT LENS AND DETECTING THE PRESENCE OF AN OXIDATIVE DISINFECTANT | Allergan (US) | 1998-04-15 | — | — | EP | disclosed |
| WO-1998005365-A2 | COMPOSITIONS AND METHODS FOR DISINFECTING CONTACT LENSES AND PRESERVING CONTACT LENS CARE PRODUCTS | ALLERGAN SALES, INC. (US) | 1998-02-12 | — | — | WO | disclosed |
| WO-1997002053-A1 | COMPOSITIONS AND METHODS FOR DISINFECTING A CONTACT LENS AND DETECTING THE PRESENCE OF AN OXIDATIVE DISINFECTANT | ALLERGAN (US) | 1997-01-23 | — | — | WO | disclosed |